PBL Company Profile
PBL Assay Science works hand in hand with industry, academic, and government researchers to help solve difficult assay and protein analyte quantification problems in Life Science/Drug/Biological development and research. With three decades of experience in ELISA and Reagent development and manufacturing, PBL may assist you in selecting appropriate assay platforms, delineating project milestones, and running samples. Using state-of-the-art technologies such as Single Molecule Array (Simoa™), Single Molecule Counting (SMC™-Erenna & SMC™-xPRO), and Meso Scale Discovery Electrochemiluminescence (MSD-ECL), PBL’s core immunoassay expertise spans ultrasensitive single analyte biomarker quantification through multiplex cytokine and biomarker assay execution. PBL also provides an extensive range of cell-based assay services including anti-proliferative activity, cytokine secretion, cytopathic effect, neutralizing activity, and antibody characterization. Whether you would like us to characterize lead compounds in cell-based activity assays or to quantify protein biomarkers sensitively in serum or plasma samples, PBL is here to serve your ‘fit for purpose’ needs.